Koers Medtronic, Inc. Nyse
Aandelen
US5850551061
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
||
- USD | - |
18:20 | Arecor Therapeutics werkt samen met Medtronic aan nieuwe insuline | AN |
13:10 | Arecor Therapeutics en Medtronic gaan samenwerken voor de ontwikkeling van thermostabiele insuline | MT |
Omzet 2024 * | 32,24 mld. 29,9 mld. | Omzet 2025 * | 33,57 mld. 31,13 mld. | Marktkapitalisatie | 108 mld. 100 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 4,56 mld. 4,23 mld. | Nettowinst (verlies) 2025 * | 5,24 mld. 4,86 mld. | EV/omzet 2024 * | 4,05 x |
Nettoschuld 2024 * | 22,21 mld. 20,6 mld. | Nettoschuld 2025 * | 21,12 mld. 19,58 mld. | EV/omzet 2025 * | 3,85 x |
K/w-verhouding 2024 * |
23,3
x | K/w-verhouding 2025 * |
20,1
x | Werknemers | - |
Dividendrendement 2024 * |
3,38% | Dividendrendement 2025 * |
3,55% | Vrij verhandelbaar | 99,81% |
Recentste transcriptie over Medtronic, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 26-01-15 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 01-06-16 |
Gregory Smith
COO | Chief Operating Officer | 63 | 01-04-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 01-01-13 |
Kendall Powell
BRD | Director/Board Member | 70 | 01-01-07 |
Randall Hogan
BRD | Director/Board Member | 68 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,87% | 183 mld. | |
-3,71% | 67,51 mld. | |
+3,60% | 50,67 mld. | |
+9,06% | 44,7 mld. | |
+2,41% | 40,95 mld. | |
+6,59% | 26,8 mld. | |
+3,64% | 26,71 mld. | |
+12,66% | 24,62 mld. | |
-13,28% | 21,38 mld. |